Kate Farms has launched high-protein plant-based shakes to tackle "critical nutrition gaps" from GLP-1 use, its first product ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Shares of WW International Inc. were climbing in early Tuesday trading, after the company known as WeightWatchers emerged from bankruptcy and announced a new program to support women through menopause ...

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...

A mother-of-three who shed two stone in just nine weeks thanks to a skinny jab has warned users of a painful side-effect that ...

Benefit managers will need to modernize their strategies and offerings around well-being, caregiving and professional ...

Fibromyalgia patients taking GLP-1s have lower rates of opioid use, pain, fatigue, and malaise in a real-world patient data ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that it will host an investor event at the Endocrine Society’s annual meeting (ENDO 2025) on Sunday, July 13, ...

The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on plus-size clothing options.

Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...